close

Enter

Log in using OpenID

Global Leukemia Therapeutics Treatment Market Growth and Trends 2015 – 2025: Report

embed
Leukemia is defined as a cancer observed in white blood cell (WBC) in our body. White blood cell helps our body to fight against infection caused by harmful pathogen. Bone marrow is the center for the production of RBC (carry oxygen to all part of b
Global Leukemia
Therapeutics
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2015
Future Market Insights
www.futuremarketinsights.com
[email protected]
Report
Description
Report Description
Leukemia is defined as a cancer observed in white blood cell (WBC) in our body. White
blood cell helps our body to fight against infection caused by harmful pathogen. Bone
marrow is the center for the production of RBC (carry oxygen to all part of body), WBC
(fight against infection) and platelets (help in blood clotting). Our bone marrow produces
abnormal WBC when we are suffering from leukemia. Moreover abnormal WBCs are not
able to perform normal functioning or WBC loses its ability to fight against infection.
Etiology for leukemia includes artificial ionizing radiation, benzene and petrochemicals,
alkylation chemotherapy agents, genetic predisposition and electromagnetic energy.
Genetic predisposition and electromagnetic energy is the most common cause of
leukemia observed among people. Signs and symptoms of leukemia includes a new lump
or swollen gland in neck and arm, frequent nosebleed, pain in the bone, night sweat and
frequent fever. Leukemia can be diagnosed by bone marrow tests, platelet count and
WBC (white blood cell) differential count test. Leukemia can be treated by blood
transfusion, immunotherapy, bone marrow transplantation, radiation therapy and
chemotherapy.
Commercially available drug in the market for the treatment of leukemia includes
Gleevec, Bosulif, Sprycel, Iclusig and others. Drugs which are in clinical trials expected to
launch in the marketwithin next few (3 to 5)years include Bosutinib, Omapro,
ga101/rg7159, Vidaza, Dacogen, Midostaurin, Vosaroxin, Quizartinib, Graspa, Marqibo.
Browse Full [email protected] http://www.futuremarketinsights.com/reports/leukemiatherapeutics-treatment-market
Report
Description
Report Description
The global market for leukemia treatment can be segmented as follows:
Based on the developmental and progression rate
• Chronic leukemia
• Acute leukemia
Chronic leukemia is a type of blood cancer caused by uncontrolled growth of the WBC
cells in our body. Chronic leukemia is a type of myeloproliferative disease which is
characterized by the chromosomal translocation. Patients suffering from chronic
leukemia show increased susceptibility to bacterial infections, thrombocytopenia and
anemia and may also have enlarged spleen which causes pain on the left side. Incidence
rate of chronic leukemia is high in men and is the second most common type of cancer
occurring in male adults. Women who are above 50 years in age are expected to suffer
from this chronic disease. Treatment for chronic leukemia depends on the phase of the
disease that can be chronic, accelerated or the blast phase and the treatment for chronic
leukemia includes chemotherapy, stem cell transplants and biologic therapies.
Acute myeloid leukemia develops at a speedy pace and is found in the blood and bone
marrow. In the disease process, immature blood cells are present in the bone marrow.
Symptoms found in patients due to the disease are flu, loss of weight, body ache, body
pain and spots on skin.Treatment for acute leukemia includes chemotherapy, stem cell
transplants and biologic therapies.
Report
Description
Report Description
About 90% of the leukemia cases occur in the middle age and progresses with the aging.
Therefore, leukemia therapeutics market is poised to grow with the rise in aging
population and increasing incidences of leukemia. Drugs such as Bosulif, Gleevec, Sprycel
andIclusigare commercially available for the treatment of leukemia. Gleevec was the first
leukemia drug introduced in 2001, since then there has been a revolutionary change in
the quality life of patients as compared to the former chemotherapy drugs.Globally the
numbers of elderly people, 60 years and above are growing and it is expected that this
age group will cross the 2 billion mark in 2050 stated by United Nations Population
Division. Hence the leukemia therapeutics market will also grow significantly. However
adverse event (cytotoxic) associated with nearly all kinds of leukemia therapeutics
treatment might restrict the global market demand of leukemia therapeutics market.
Request Report [email protected] http://www.futuremarketinsights.com/toc/rep-gb-421
North America dominates the global market for leukemia therapeutics treatment due to
high prevalence rate of leukemia (acute, chronic) and extensive technological
advancement (diagnosis) in this region. Europe represents the second largest market
share due to its large geriatric population base. In addition Asia-Pacific and RoW hold the
third and fourth position in the global leukemia therapeutics market respectively due to
less prevalence rate of leukemia and lack of proper healthcare facilities in few Asian and
African countries.
North America accounted for 62% sales of leukemia drugs in the therapeutics market
during 2010 followed by Europe and Asia Pacific.
Report
Description
Report Description
Leukemia therapeutics market will grow significantlyand the total growth will depend on
pipeline products and metabolic inhibitors, a tyrosine kinase receptor FLT -3 of Novartis
and some other capable molecules, improving the therapeutics market.
Major market playerscontributing the global market share of leukemia therapeutics
treatment includes Ambit Biosciences Corporation, AriadPharmaceuticals,Inc., Biogen
Idec, Inc., Novartis Pharmaceuticals, Bristol-Myers Squibb, Pfizer and others.
About Us
Report
Description
Future
Market
Insights
Future Market Insights (FMI) is a premier provider of syndicated
research reports, custom research reports, and consulting services.
We deliver a complete packaged solution, which combines current
market intelligence, statistical anecdotes, technology inputs,
valuable growth insights, aerial view of the competitive
framework, and future market trends.
We provide research services at a global as well as regional level;
key regions include GCC, ASEAN, and BRIC.
Research Capabilities




Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage








Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705
Author
Ethansmith
Ethansmith84   documents Email
Document
Category
Health and Medicine
Views
44
File Size
462 KB
Tags
leukemia
1/--pages
Report inappropriate content